Our lab studies the role of metabolic reprogramming in cancer, cardiomyopathy and fatty liver disease. We combine metabolomics and genetics to identify crucial metabolic pathways and processes with the aim of developing new treatment strategies.
Professor Eyal Gottlieb
Director, the Rappaport Institute for Medical Research
Laura and Isaac Perlmutter Chair of Cancer Research
Director of the Laura and Isaac Perlmutter Metabolomics Center
Education
1990 BSc, Agriculture, The Hebrew University, Israel
1993 MSc, Molecular Cell Biology, Weizmann Institute of Science, Israel
1998 PhD, Molecular Cell Biology, Weizmann Institute of Science, Israel
2020 MBA, Faculty of Industrial Engineering and Management, Technion – Israel Institute of Technology, Israel
Previous Academic Positions
1998 – 1999 Postdoctoral Fellow, University of Chicago, Chicago IL, USA
1999 – 2003 Postdoctoral Fellow, University of Pennsylvania, Philadelphia PA, USA
2003 – 2009 Research Group Leader, Cancer Research UK, Beatson Institute, Glasgow, UK
2009 – 2018 Senior Research Group leader, Cancer Research UK, Beatson Institute, Glasgow, UK
2013 – 2018 Director, Cancer Metabolism Research Unit, Cancer Research UK, Beatson Institute, Glasgow, UK
Other Current Professional Activities
Visiting Professor, Norwegian Centre for Cancer Biomedicine, Oslo, Norway
Senior Editor, Cancer Research
Executive Director, MetaboMed Ltd, Yavne, Israel